Cytokinetics ticker

WebTicker CYTK. Exchange NASDAQ More. ... Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Visit website. Social Media Links. Cytokinetics. Most Recent … WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …

CYTK Stock Forecast, Price & News (Cytokinetics)

WebJul 19, 2024 · The data suggest that Cytokinetics (ticker: CYTK) drug could become a potent rival to a similar investigational drug that Bristol Myers Squibb (BMY) acquired last … WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, … sigma on keyboard iphone https://omnimarkglobal.com

Cytokinetics Muscle Biology Therapies Home

WebJun 27, 2024 · Cytokinetics ( NASDAQ: CYTK) is a developer of small molecule drugs for cardiovascular and neuromuscular diseases of impaired muscle function. The lead drug … WebBonnie Charpentier SVP Regulatory & Compliance at Cytokinetics, is currently unranked, see this insider's latest transactions. Top Stocks. Top Analyst Stocks Top Smart Score Stocks ... SVP Regulatory & Compliance at Cytokinetics, holds 0.00 shares in Cytokinetics (Ticker: CYTK). See the Hottest Stocks Based on Insider Trading > Bonnie ... WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. the printhouse new rochelle apartments

Cytokinetics - Overview, News & Competitors ZoomInfo.com

Category:CYTK Cytokinetics Inc. Profile MarketWatch

Tags:Cytokinetics ticker

Cytokinetics ticker

Cytokinetics Announces Topline Results From METEORIC-HF

WebJun 27, 2024 · CYTK has a market cap of $4.05bn and a cash balance of $686mn. Research and development expenses for the first quarter 2024 were $45.9 million, while general and administrative expenses were $33.1... WebCytokinetics Inc. Annual stock financials by MarketWatch. View the latest CYTK financial statements, income statements and financial ratios.

Cytokinetics ticker

Did you know?

WebMar 1, 2024 · Cytokinetics Inc (CYTK) SEC Filing 8-K Material Event for the period ending Wednesday, March 1, 2024. Home. SEC Filings. Cytokinetics Inc (CYTK) 8-K Material Event Wed Mar 01 2024; SEC Filings. CYTK Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. WebApr 20, 2024 · Is CYTK stock a buy? Hedge fund interest in Cytokinetics, Inc. (NASDAQ: CYTK) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that...

WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … WebCytokinetics is a Biotechnology Research, Drug Manufacturing & Research, and Biopharma company located in South San Francisco, California with $26.00 Million in revenue and 495 employees. Find top employees, contact details and business statistics at RocketReach. ... Ticker: CYTK Revenue: $26 million: Funding: $222.70 Million: …

WebCytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 34.71 -0.54 (-1.53%) As of 10:34AM EDT. Market open.

WebMar 31, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the …

WebCytokinetics is a biopharmaceutical company developing therapies for debilitating diseases. South San Francisco, California, United States 251-500 Post-IPO Debt Public cytokinetics.com 1,449 Highlights Stock … the print icon is missingWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has … the print hubWebFeb 15, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced topline results from METEORIC-HF ( M ulticenter E xercise T olerance E... the print icon appears on standard toolbarWebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … sigma origin storyWebTicker: CYTK; CUSIP Number: 23282w605; Tip: Access positions for across all investors ... By clicking the button below, your credit card will be charged $28.00 USD (one time) and you'll have access to all Cytokinetics position data for 90 days. Purchase access * Investors with a full data subscription can access data for any fund and any ticker ... the print house vancouverWebMar 4, 2024 · Today is shaping up negative for Cytokinetics, ... (ticker: BBBY) stock was down nearly 20% at 83 cents. In a reverse stock split, each outstanding share is converted into a fraction of the share. the print hub cardiffWebDec 30, 2024 · Mizuho Securities analyst Salim Syed maintained a Buy rating on Cytokinetics (CYTK - Research Report) today and set a price target of $80.00. The … sigma ortho